These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8513956)

  • 1. Age-related changes in the metoclopramide-induced prolactin release in nulliparous women.
    Parra A; Alarcón J; Gaviño F; Ramírez A; Espinosa de los Monteros A
    Fertil Steril; 1993 Jul; 60(1):34-9. PubMed ID: 8513956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum prolactin during oral metoclopramide in normal nulliparous women].
    Ramírez A; Espinosa de los Monteros A; Coria I; Hortencia Valencia Q; Parra A
    Ginecol Obstet Mex; 1993 Apr; 61():96-101. PubMed ID: 8406122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential prolactin response to oral metoclopramide in nulliparous versus parous women throughout the menstrual cycle.
    Espinosa de los Monteros A; Cornejo J; Parra A
    Fertil Steril; 1991 May; 55(5):885-9. PubMed ID: 2022267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the metoclopramide-induced prolactin release related to age at first full-term pregnancy or nulliparity.
    Parra A; Barrón J; Sinibaldi J; Coria I; Espinosa de los Monteros A
    Hum Reprod; 1997 Feb; 12(2):214-9. PubMed ID: 9070698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal and metoclopramide-stimulated prolactin (PRL) serum levels in users and non-users of a copper intrauterine device (TCu-380 IUD).
    Parra A; Gabiño F; Ramírez A; Valencia H; Coria I; Espinosa de los Monteros A
    Contraception; 1991 Nov; 44(5):541-7. PubMed ID: 1797468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of parity on pituitary prolactin response to metoclopramide and domperidone: implications for the enhancement of lactation.
    Brown TE; Fernandes PA; Grant LJ; Hutsul JA; McCoshen JA
    J Soc Gynecol Investig; 2000; 7(1):65-9. PubMed ID: 10732318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased hypothalamic dopaminergic tone only in early parous women with either malignant or benign breast tumors.
    Ortega-González C; Parra A; Barra R; Aranda C; Ramírez D; Di Castro P; Castro I; Zambrana M; Coria I
    Endocr Pract; 2002; 8(2):89-95. PubMed ID: 11942771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased dopaminergic tone and increased basal bioactive prolactin in men with human immunodeficiency virus infection.
    Parra A; Ramírez-Peredo J; Larrea F; Cabrera V; Coutiño B; Torres I; Angeles A; Pérez-Romano B; Ruiz-Argüelles G; Ruiz-Argüelles A
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):731-8. PubMed ID: 11422107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ghrelin and metoclopramide on prolactin secretion in normal women.
    Messini CI; Dafopoulos K; Chalvatzas N; Georgoulias P; Anifandis G; Messinis IE
    J Endocrinol Invest; 2011 Apr; 34(4):276-9. PubMed ID: 20530986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin secretion during pregnancy and puerperium: response to metoclopramide and interactions with placental hormones.
    Bohnet HG; Kato K
    Obstet Gynecol; 1985 Jun; 65(6):789-92. PubMed ID: 3839061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1988 Apr; 11(4):255-9. PubMed ID: 3137253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of defective lactation by using oral metoclopramide.
    Guzmán V; Toscano G; Canales ES; Zárate A
    Acta Obstet Gynecol Scand; 1979; 58(1):53-5. PubMed ID: 369279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased dopaminergic activity inhibits basal and metoclopramide-stimulated prolactin and thyrotropin secretion.
    Agner T; Hagen C; Andersen AN; Djursing H
    J Clin Endocrinol Metab; 1986 Apr; 62(4):778-82. PubMed ID: 3949956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin (PRL) release in normal and growth hormone deficient children after oral metoclopramide.
    Preeyasombat C; Mahachoklertwattana P; Sriphrapradang A; Choubtam L
    J Med Assoc Thai; 1993 Oct; 76 Suppl 2():34-41. PubMed ID: 7823004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered functional status of the hypothalamic dopaminergic tone in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a pilot study.
    Parra A; Ramírez-Peredo J; Hidalgo R; Morales-Toquero A; Velásquez-Ramírez G; Ruiz-Argüelles A; Ruiz-Argüelles GJ
    Biol Blood Marrow Transplant; 2006 May; 12(5):566-72. PubMed ID: 16635792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metoclopramide and quipazine on serum prolactin concentrations in steers.
    Lipham LB; Thompson FN; Stuedemann JA
    J Vet Pharmacol Ther; 1992 Mar; 15(1):78-84. PubMed ID: 1573708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin.
    Méndez I; Alcocer-Varela J; Parra A; Lava-Zavala A; de la Cruz DA; Alarcón-Segovia D; Larrea F
    Lupus; 2004; 13(1):45-53. PubMed ID: 14870917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of basal and metoclopramide-induced prolactin release by cabergoline, an extremely long-acting dopaminergic drug.
    Pontiroli AE; Cammelli L; Baroldi P; Pozza G
    J Clin Endocrinol Metab; 1987 Nov; 65(5):1057-9. PubMed ID: 3667876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia.
    Lissoni P; Mandalà M; Rovelli F; Casu M; Rocco F; Tancini G; Scardino E
    Eur Urol; 2000 May; 37(5):569-72. PubMed ID: 10765095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.